Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
106(10):2930-2945
but does not affect an established asthmatic attack
A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques
44)45)13-23(35)29(19)33(31)41)18-4-6-26(16(2)8-18)38-40-32-28(58(52
IV) significantly inhibits platelet thrombus formation
ONO-4059 (analog) or modulator-1 106(10):2930-2945ONO 4059 analog is the analog of ONO 4059, ONO 4059 is a highly potent and selective Btk inhibitor. IC50 value: sub nM range Target: Btkin vitro: ONO 4059 is a selective, once daily, oral inhibitor of BTK, which has been shown to play a role in the survival and proliferation of malignant B cells. ONO 4059 shows a favourable safety profile along with promising efficacy in this difficult to treat patient population. in vivo: ONO 4059 has demonstrated
US$ 38.00
US$ 48.00
US$ 85.00
US$ 38.00
US$ 275.00
US$ 68.00
US$ 70.00
US$ 38.00